Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 3
2012 1
2016 2
2017 4
2018 3
2019 2
2020 3
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
Ždralević M, Brand A, Di Ianni L, Dettmer K, Reinders J, Singer K, Peter K, Schnell A, Bruss C, Decking SM, Koehl G, Felipe-Abrio B, Durivault J, Bayer P, Evangelista M, O'Brien T, Oefner PJ, Renner K, Pouysségur J, Kreutz M. Ždralević M, et al. Among authors: durivault j. J Biol Chem. 2018 Oct 12;293(41):15947-15961. doi: 10.1074/jbc.RA118.004180. Epub 2018 Aug 29. J Biol Chem. 2018. PMID: 30158244 Free PMC article.
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells.
Penco-Campillo M, Comoglio Y, Feliz Morel ÁJ, Hanna R, Durivault J, Leloire M, Mejias B, Pagnuzzi M, Morot A, Burel-Vandenbos F, Selby M, Williamson D, Clifford SC, Claren A, Doyen J, Picco V, Martial S, Pagès G. Penco-Campillo M, et al. Among authors: durivault j. Commun Biol. 2020 Oct 16;3(1):579. doi: 10.1038/s42003-020-01306-4. Commun Biol. 2020. PMID: 33067561 Free PMC article.
Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells.
Penco-Campillo M, Comoglio Y, Feliz Morel ÁJ, Hanna R, Durivault J, Leloire M, Mejias B, Pagnuzzi M, Morot A, Burel-Vandenbos F, Selby M, Williamson D, Clifford SC, Claren A, Doyen J, Picco V, Martial S, Pagès G. Penco-Campillo M, et al. Among authors: durivault j. Commun Biol. 2020 Dec 7;3(1):758. doi: 10.1038/s42003-020-01502-2. Commun Biol. 2020. PMID: 33288846 Free PMC article.
The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor.
Grépin R, Guyot M, Dumond A, Durivault J, Ambrosetti D, Roussel JF, Dupré F, Quintens H, Pagès G. Grépin R, et al. Among authors: durivault j. Theranostics. 2020 Jan 1;10(3):1107-1121. doi: 10.7150/thno.38346. eCollection 2020. Theranostics. 2020. PMID: 31938054 Free PMC article.
VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness.
Ndiaye PD, Dufies M, Giuliano S, Douguet L, Grépin R, Durivault J, Lenormand P, Glisse N, Mintcheva J, Vouret-Craviari V, Mograbi B, Wurmser M, Ambrosetti D, Rioux-Leclercq N, Maire P, Pagès G. Ndiaye PD, et al. Among authors: durivault j. Theranostics. 2019 Jan 21;9(3):661-675. doi: 10.7150/thno.27794. eCollection 2019. Theranostics. 2019. PMID: 30809300 Free PMC article.
Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma.
Dumond A, Brachet E, Durivault J, Vial V, Puszko AK, Lepelletier Y, Montemagno C, Pagnuzzi-Boncompagni M, Hermine O, Garbay C, Lagarde N, Montes M, Demange L, Grépin R, Pagès G. Dumond A, et al. Among authors: durivault j. J Exp Clin Cancer Res. 2021 Jan 18;40(1):33. doi: 10.1186/s13046-021-01832-x. J Exp Clin Cancer Res. 2021. PMID: 33461580 Free PMC article.
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page